1 Vaccines Market Overview
1.1 Product Overview and Scope of Vaccines
1.2 Vaccines Segment by Type
1.2.1 Global Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Recombinant Vaccines
1.2.3 Viral Vaccines
1.2.4 Polysaccharide Vaccines
1.2.5 Others
1.3 Vaccines Segment by Application
1.3.1 Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Cholera
1.3.3 Hepatitis B
1.3.4 Diphtheria
1.3.5 Tetanus
1.3.6 Measles Vaccine
1.3.7 Hepatitis A
1.3.8 Live Attenuated Influenza Vaccine
1.3.9 Polio Vaccine
1.3.10 Rabies Vaccine
1.4 Global Vaccines Market Size Estimates and Forecasts
1.4.1 Global Vaccines Revenue 2016-2027
1.4.2 Global Vaccines Sales 2016-2027
1.4.3 Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Vaccines Market Competition by Manufacturers
2.1 Global Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Vaccines Market Competitive Situation and Trends
2.5.1 Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Vaccines Players Market Share by Revenue
2.5.3 Global Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Vaccines Retrospective Market Scenario by Region
3.1 Global Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Vaccines Market Facts & Figures by Country
3.3.1 North America Vaccines Sales by Country
3.3.2 North America Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vaccines Market Facts & Figures by Country
3.4.1 Europe Vaccines Sales by Country
3.4.2 Europe Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccines Sales by Region
3.5.2 Asia Pacific Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vaccines Market Facts & Figures by Country
3.6.1 Latin America Vaccines Sales by Country
3.6.2 Latin America Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccines Sales by Country
3.7.2 Middle East and Africa Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Vaccines Historic Market Analysis by Type
4.1 Global Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Vaccines Price by Type (2016-2021)

5 Global Vaccines Historic Market Analysis by Application
5.1 Global Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Vaccines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GSK Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Sanofi Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Novartis(GSK)
6.5.1 Novartis(GSK) Corporation Information
6.5.2 Novartis(GSK) Description and Business Overview
6.5.3 Novartis(GSK) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Novartis(GSK) Product Portfolio
6.5.5 Novartis(GSK) Recent Developments/Updates
6.6 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 CSL Product Portfolio
6.6.5 CSL Recent Developments/Updates
6.7 MedImmune LLC
6.6.1 MedImmune LLC Corporation Information
6.6.2 MedImmune LLC Description and Business Overview
6.6.3 MedImmune LLC Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 MedImmune LLC Product Portfolio
6.7.5 MedImmune LLC Recent Developments/Updates
6.8 J&J(Crucell)
6.8.1 J&J(Crucell) Corporation Information
6.8.2 J&J(Crucell) Description and Business Overview
6.8.3 J&J(Crucell) Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 J&J(Crucell) Product Portfolio
6.8.5 J&J(Crucell) Recent Developments/Updates
6.9 China National Biotec
6.9.1 China National Biotec Corporation Information
6.9.2 China National Biotec Description and Business Overview
6.9.3 China National Biotec Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 China National Biotec Product Portfolio
6.9.5 China National Biotec Recent Developments/Updates
6.10 Tiantan
6.10.1 Tiantan Corporation Information
6.10.2 Tiantan Description and Business Overview
6.10.3 Tiantan Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Tiantan Product Portfolio
6.10.5 Tiantan Recent Developments/Updates
6.11 Hualan
6.11.1 Hualan Corporation Information
6.11.2 Hualan Vaccines Description and Business Overview
6.11.3 Hualan Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Hualan Product Portfolio
6.11.5 Hualan Recent Developments/Updates
6.12 Kangtai
6.12.1 Kangtai Corporation Information
6.12.2 Kangtai Vaccines Description and Business Overview
6.12.3 Kangtai Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Kangtai Product Portfolio
6.12.5 Kangtai Recent Developments/Updates
6.13 Hissen
6.13.1 Hissen Corporation Information
6.13.2 Hissen Vaccines Description and Business Overview
6.13.3 Hissen Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Hissen Product Portfolio
6.13.5 Hissen Recent Developments/Updates
6.14 Jintan
6.14.1 Jintan Corporation Information
6.14.2 Jintan Vaccines Description and Business Overview
6.14.3 Jintan Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Jintan Product Portfolio
6.14.5 Jintan Recent Developments/Updates

7 Vaccines Manufacturing Cost Analysis
7.1 Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccines
7.4 Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vaccines Distributors List
8.3 Vaccines Customers

9 Vaccines Market Dynamics
9.1 Vaccines Industry Trends
9.2 Vaccines Growth Drivers
9.3 Vaccines Market Challenges
9.4 Vaccines Market Restraints

10 Global Market Forecast
10.1 Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Vaccines by Type (2022-2027)
10.2 Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Vaccines by Application (2022-2027)
10.3 Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer